Analysts expect Ionis Pharmaceuticals Inc to report revenue of 187.96 M for Q3 26, against a range of 181.38 M to 194.54 M. The most recent reported quarter, Q2 26, came in at 268.00 M, a 33.3% beat against the 201.04 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 134.00 M | 227.00 M | 132.00 M | 452.00 M | 157.00 M | 203.00 M | 246.00 M | 268.00 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 136.70 M | 140.95 M | 135.39 M | 337.20 M | 144.45 M | 183.56 M | 190.53 M | 211.66 M | 194.54 M | 259.73 M | 275.64 M | 297.84 M | 222.96 M | 328.54 M | 484.23 M | 683.50 M | ||||||||||
| Low Estimate | 114.49 M | 115.86 M | 113.68 M | 284.97 M | 129.65 M | 150.47 M | 178.50 M | 190.42 M | 181.38 M | 240.38 M | 242.90 M | 248.32 M | 198.26 M | 307.75 M | 448.57 M | 633.61 M | ||||||||||
| Consensus Estimate | 125.60 M | 128.40 M | 124.54 M | 311.09 M | 137.05 M | 167.02 M | 184.52 M | 201.04 M | 187.96 M | 250.05 M | 259.27 M | 273.08 M | 210.61 M | 318.15 M | 466.40 M | 658.55 M |
Analysts expect Ionis Pharmaceuticals Inc to report earnings per share of -1.16 for Q3 26, against a range of -1.21 to -1.11. The most recent reported quarter, Q2 26, came in at -0.69, a 34.3% beat against the -1.05 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.95 | -0.66 | -0.93 | 0.70 | -0.80 | -1.41 | -0.56 | -0.69 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.14 | -1.06 | -1.08 | -0.09 | -1.11 | -1.31 | -0.85 | -0.98 | -1.11 | -0.95 | -0.81 | -0.68 | -1.16 | -0.92 | 0.26 | 0.47 | ||||||||||
| Low Estimate | -1.28 | -1.24 | -1.22 | -0.09 | -1.25 | -1.39 | -0.97 | -1.12 | -1.21 | -1.05 | -0.95 | -0.76 | -1.40 | -1.08 | 0.22 | 0.41 | ||||||||||
| Consensus Estimate | -1.21 | -1.15 | -1.15 | -0.09 | -1.18 | -1.35 | -0.91 | -1.05 | -1.16 | -1.00 | -0.88 | -0.72 | -1.28 | -1.00 | 0.24 | 0.44 |
Pull Wall Street consensus for Ionis Pharmaceuticals Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IONS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IONS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IONS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();